Myasthenia Gravis: Christopher Klein, M.D.

(00:34) I'm joined here today by Dr. Chris Klein. Sir, would you mind introducing yourself to our audience and telling them a little bit about your background?

(1:19) I don't want this to be a review of the paper, sir, but could you just give maybe a recap of one or some of the key takeaways?

(5:59) It was one of the first tests discovered, but we're not satisfied with the status quo and we continue to look for ways to make it better?

(6:41) Can you just help the audience understand why that's necessary and why it's the best thing for patient care?

(9:30) I think the role of MuSK is well understood, but it is a slight change in that it's going to automatically reflex. But the point of that is also to reduce turnaround time, right?

(11:17) It sounds like it'd be hard to give a definitive diagnosis without the testing that we're offering right now, right?

(13:13) What advice would you give for physicians or even laboratorians that might be trying to use our tests most efficiently?

(17:00) What would you say Dr. Klein, to conclude, that you're most excited about regarding these changes that may have occurred?